Is Most-Watched Stock Intuitive Surgical, Inc. (ISRG) Worth Betting on Now?

Core Viewpoint - Intuitive Surgical, Inc. (ISRG) has experienced a stock return of -5.6% over the past month, underperforming the Zacks S&P 500 composite's +3.1% and the Zacks Medical - Instruments industry's -5.4% [1] Earnings Estimate Revisions - The consensus earnings estimate for the current quarter is $1.99 per share, reflecting a year-over-year increase of +8.2% [4] - The consensus earnings estimate for the current fiscal year is $8.17, indicating a year-over-year change of +11.3%, remaining unchanged over the last 30 days [4] - For the next fiscal year, the consensus earnings estimate is $9.18, representing a +12.4% change from the previous year, with a slight decrease of -0.2% over the past month [5] - Intuitive Surgical has a Zacks Rank 4 (Sell), indicating potential underperformance in the near term due to recent changes in earnings estimates [6] Revenue Growth Forecast - The consensus sales estimate for the current quarter is $2.41 billion, showing a year-over-year increase of +18.2% [10] - For the current fiscal year, the sales estimate is $9.78 billion, indicating a +17.1% change, while the next fiscal year's estimate is $11.14 billion, reflecting a +14% change [10] Last Reported Results and Surprise History - In the last reported quarter, Intuitive Surgical generated revenues of $2.44 billion, a year-over-year increase of +21.4%, with an EPS of $2.19 compared to $1.78 a year ago [11] - The company reported a revenue surprise of +3.93% compared to the Zacks Consensus Estimate and an EPS surprise of +14.06% [11] - Intuitive Surgical has consistently beaten consensus EPS estimates in the last four quarters and topped revenue estimates three times during this period [12] Valuation - Intuitive Surgical is graded D on the Zacks Value Style Score, indicating it is trading at a premium compared to its peers [16]